CHA Vaccine Research Institute (KOSDAQ:261780)

KOSDAQ:261780 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,085	10,092	5,906	2,386	3,955	11,838
Short-Term Investments	24,550	22,550	32,990	55,377	47,500	3,000
Trading Asset Securities	5,261	7,465	-	-	10,095	9,989
Cash & Short-Term Investments	33,896	40,107	38,896	57,763	61,550	24,827
Cash Growth	-3.57%	3.11%	-32.66%	-6.15%	147.92%	179.65%
Accounts Receivable	0	-0	0	-0	-0	-0
Other Receivables	953.33	399.87	453.87	607.81	266.9	188.2
Receivables	953.33	399.87	453.87	607.8	266.9	188.2
Prepaid Expenses	86.35	106.63	94.23	117.1	12.94	8.52
Other Current Assets	5,371	3,977	3,042	429	17.07	13.91
Total Current Assets	40,307	44,590	42,486	58,917	61,847	25,037
Property, Plant & Equipment	1,023	1,120	1,644	1,543	1,032	586.81
Long-Term Investments	1,161	1,069	674.6	440	2,300	-
Other Intangible Assets	224.12	174.67	43.58	39.91	21.77	28.86
Long-Term Accounts Receivable	0	0	0	0	0	0
Other Long-Term Assets	288.42	294.39	270.9	129.08	112.5	94.43
Total Assets	43,003	47,248	45,119	61,069	65,313	25,747
Accrued Expenses	150.51	129.31	146.74	77.43	60.77	63
Short-Term Debt	5,527	4,950	-	23,240	20,717	-
Current Portion of Leases	8.12	8.35	162.92	381.21	112.8	101.77
Other Current Liabilities	4,975	4,526	500.53	3,090	3,816	4,641
Total Current Liabilities	10,661	9,613	810.18	26,789	24,706	4,806
Long-Term Debt	5,101	4,627	3,975	-	-	18,610
Long-Term Leases	-	3.81	188.65	16.53	16.14	128.94
Other Long-Term Liabilities	4,050	3,662	3,525	15.09	237.52	186.68
Total Liabilities	21,643	19,526	9,702	27,703	25,698	24,174
Common Stock	13,433	13,412	13,366	13,215	13,215	11,194
Additional Paid-In Capital	79,870	79,687	76,782	72,576	72,576	18,404
Retained Earnings	-72,409	-65,920	-55,457	-53,615	-46,921	-28,335
Comprehensive Income & Other	466.02	542.97	725.68	1,190	745.6	310.07
Shareholders' Equity	21,360	27,722	35,417	33,366	39,615	1,573
Total Liabilities & Equity	43,003	47,248	45,119	61,069	65,313	25,747
Total Debt	10,636	9,589	4,327	23,638	20,846	18,840
Net Cash (Debt)	23,260	30,518	34,569	34,125	40,704	5,986
Net Cash Growth	-23.35%	-11.72%	1.30%	-16.16%	579.94%	64.00%
Net Cash Per Share	867.49	1138.75	1304.13	1290.78	1745.71	333.84
Filing Date Shares Outstanding	26.87	26.82	26.73	26.43	26.43	17.93
Total Common Shares Outstanding	26.87	26.82	26.73	26.43	26.43	17.93
Working Capital	29,646	34,977	41,676	32,128	37,141	20,231
Book Value Per Share	795.07	1033.46	1324.89	1262.45	1498.91	87.72
Tangible Book Value	21,136	27,548	35,373	33,326	39,593	1,544
Tangible Book Value Per Share	786.72	1026.95	1323.26	1260.94	1498.09	86.11
Land	95.09	95.09	95.09	95.09	95.09	95.09
Buildings	402.68	402.68	402.68	402.68	402.68	402.68
Machinery	2,185	2,086	1,933	1,622	1,079	410.3

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.